CClinicalTrials.gg
CompletedNCT03917771Updated Apr 17, 2019

Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer

An interventional study of Early lymphedema detection and Usual follow-up in Lymphedema of Limb and Sentinel Lymph Node, sponsored by Hospital Donostia. Completed at 1 site in Spain. Open to female participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-04-17.

Sponsored by Hospital Donostia · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Apr 2017, registered Aug 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
Female
01

Study summary

This study aims to detect and treat early lower limb lymphedema secondary to lymphadenectomy with the aim of increasing the quality of life of patients with this chronic condition.

To this end, a group of patients (treatment group) will be referred to the Rehabilitation service for a previous consultation and after surgery where lymphedema could be detected early. In addition, the usual follow-up will be carried out in Gynecology Oncology consultation (GO). In the second group, also called control, will be performed the usual follow-up in GO.

For this we randomize to one of these two groups. The research project has the favorable report of the Center's Clinical Research Ethics Committee

Read the detailed description

METHODOLOGY:

  1. Type of study: A) Randomized clinical trial B) Prospective cohort observational study
  2. Study period: from January 2017 to December 2017.
  3. Scope: health area of the province of Gipuzkoa and the University Hospital of Donostia as a reference center.
  4. Selection of the population:

    4.1. The inclusion criteria will be: A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent 4.2. The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.

    4.3. Sample size: A) Assuming that according to previous studies the overall incidence of lymphedema after LPL is 21% (Hareyama et al), its estimated that a minimum sample of 44 patients will bi needed in order to be able to demonstrate at least 4-fold detection (Torres et al) of Lymphedemas with early follow-up with alpha = 0.05 and beta = 0.2, estimating that habitual follow-up detects 13% of lymphedema ( Mohler III et al).

    4.4. Recruitment Process: Will be selected consecutively and offered to participate in the study.

  5. 5.1 Intervention: A) After diagnosis and programming for surgery at the GO consultation, circometry is performed by a trained nurse. During the admission, the nurse delivers and explains recommendations sheet and is offered to participate in the clinical trial giving him the Informed Consent (IC) and Information Sheet created for this purpose. In case of accepting and signing the IC, it is randomized (total randomization) according to system of envelopes with code.

Distribution of the intervention;

  • Treatment group: Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education
  • Control group: The usual follow-up will be carried out in GO consultation (0,1,6,12 months)

The pelvic lymphadenectomy will be performed by the same surgical team using a transperitoneal approach. The limits of lymph node dissection will be: the psoas muscle, laterally, the postero-medially internal iliac artery, the bifurcation of the common iliac artery cranially, where it crosses the ureter, and caudally the origin of the epigastric vessels, to level of the deep circumflex iliac vein.

B) After diagnosis and programming for surgery at the GO consultation, circometry is performed by trained and yearly nurse. During the entrance, it is delivered and explains the recommendations sheet. SNB is performed by detecting sentinel ganglion from the above mentioned areas according to the protocol of the service. The usual follow-up will be carried out in GO consultation (0,1,6,12 months)

02

Conditions studied

  • Lymphedema of Limb
  • Sentinel Lymph Node

Browse trials for

Keywords

  • physiotherapy
03

In context

Lymphedema

560 studies on the registry are indexed under Lymphedema; 135 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 403 interventional studies indexed under Lymphedema.

Browse Lymphedema studies →

Lead sponsor

Hospital Donostia is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent

Exclusion criteria

Exclusion Criteria:

  • The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Early lymphedema detection

    Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery. Lower Limb measurement and care education

    Other: Early lymphedema detection

  • Active comparator
    Usual follow-up

    The usual follow-up will be carried out in GO consultation (0,1,6,12 months)

    Other: Usual follow-up

Interventions

  • OtherEarly lymphedema detection

    Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education

  • OtherUsual follow-up

    Usual follow-up carried out in GO consultation

06

What researchers measure

Primary outcomes

  1. Efficacy of the implantation of a standardized postoperative follow-up for the early detection of lymphedema secondary to lymphadenectomy in gynecological cancer

    Lower Limb measurement secondary to lymphadenectomy in gynecological cancer

    Time frame: 12 months

Secondary outcomes

  1. Implementation of educational strategy for patients and professionals

    Care education questionnaire results

    Time frame: 12 months

07

Study locations

1 site
  • Donostia Hospital
    San Sebastián, Gipuzkoa 20014, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03917771
Lead sponsor
Hospital Donostia
Responsible party
IBON JAUNARENA (Oncology Gynecologist, Hospital Donostia) — Principal investigator
First posted
Apr 17, 2019
Start date
Apr 1, 2017
Primary completion
Aug 1, 2018
Completion
Aug 1, 2018
Last update
Apr 17, 2019

Study contacts

IBON JAUNARENA
principal investigator · Hospital Donostia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion